venture capital firm investing at the frontiers of technology, healthcare and the life sciences.
Section 32 is a venture capital fund investing at the frontiers of technology, healthcare and the life sciences. Founded by Bill Maris.
Section 32 focus areas include biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence.
The firm’s goal is to improve the human condition by accelerating the discovery, development, adoption and distribution of important technologies and life saving medicines.
Visit website: https://section32.com/
People at Section 32
Section 32 News
Bill Maris brings new people for his new venture-section 32
CNBC - 20-May-2020
Calico creator is now investing on frontier technology, healthcare & lifescienceRead more...